EWEdwards Lifesciences Corporation
87.66USD+2.19%Mkt Cap: 50.54B USDP/E: 47.44Last update: 2026-05-26

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…

Indicators:|

Key Statistics

Company
Market Cap50.54B USD
Enterprise Value44.94B USD
Revenue (TTM)6.30B USD
Gross Profit4.73B USD
Net Income (TTM)1.07B USD
Revenue/Share10.81 USD
Last Price87.66 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS28176E1082
Valuation
P/E (Trailing)47.44
P/E (Forward)24.74
PEG2.00
EV/EBITDA23.61
EV/Revenue7.13
P/S7.60
P/B4.65
EPS (TTM)1.85
EPS (Forward)3.36
52W Range
72.3099% of range87.89
52W High87.89 USD
52W Low72.30 USD
Profitability
Gross Margin78.01%
Oper. Margin31.22%
EBITDA Margin30.20%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth16.70%
Earnings Growth8.20%
Cash Flow & Leverage
Operating CF1.60B USD
CapEx (TTM)260.20M USD
FCF Margin14.31%
FCF Yield1.79%
Net Debt-2.97B USD
Net Debt/EBITDA-1.56
Balance Sheet
Debt/Equity0.07
Current Ratio4.42
Quick Ratio3.30
Book Value/Sh17.90 USD
Cash/Share6.376 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)97.15 USD
Target Range84.00 USD110.00 USD
# Analysts27
Ownership
Shares Out.575.80M
Float573.95M
Insiders0.18%
Institutions94.28%
Short Interest
Short Ratio1.9d
Short % Float2.08%
Short % Out.1.83%
Shares Short10.54M
Short (prev mo.)9.97M
Technical
SMA 5081.43 (+7.6%)
SMA 20081.29 (+7.8%)
Beta0.87
S&P 52W Chg28.31%
Avg Vol (30d)5.11M
Avg Vol (10d)4.37M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)